PT1303302E - Utilização de estirpes de parapoxvirus ovis contra fibroses de órgãos - Google Patents

Utilização de estirpes de parapoxvirus ovis contra fibroses de órgãos Download PDF

Info

Publication number: PT1303302E
Authority: PT; Portugal
Prior art keywords: strains; organ fibrosis; virus against; fibrosis; against organ
Prior art date: 2000-07-11

Application number

PT01965110T

Other languages

English (en)

Portuguese (pt)

Inventor

Olaf Weber

Tobias Schlapp

Angela Siegling

Claudia Hirth-Dietrich

Gudrun Theiss

Andreas Knorr

Original Assignee

Aicuris Gmbh & Co Kg

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2000-07-11

Filing date

2001-07-11

Publication date

2009-11-11

2001-07-11 Application filed by Aicuris Gmbh & Co Kg filed Critical Aicuris Gmbh & Co Kg

2009-11-11 Publication of PT1303302E publication Critical patent/PT1303302E/pt

Links

206010016654 Fibrosis Diseases 0.000 title abstract 3
230000004761 fibrosis Effects 0.000 title abstract 3
241000283898 Ovis Species 0.000 title 1
241000700605 Viruses Species 0.000 title 1
210000000056 organ Anatomy 0.000 title 1
239000003814 drug Substances 0.000 abstract 2
102000008186 Collagen Human genes 0.000 abstract 1
108010035532 Collagen Proteins 0.000 abstract 1
241000700639 Parapoxvirus Species 0.000 abstract 1
229920001436 collagen Polymers 0.000 abstract 1
201000010099 disease Diseases 0.000 abstract 1
208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 1
230000002828 effect on organs or tissue Effects 0.000 abstract 1
230000000694 effects Effects 0.000 abstract 1
210000004024 hepatic stellate cell Anatomy 0.000 abstract 1
230000003449 preventive effect Effects 0.000 abstract 1
230000009466 transformation Effects 0.000 abstract 1

Classifications

- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/66—Microorganisms or materials therefrom
- A61K35/76—Viruses; Subviral particles; Bacteriophages
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
- A61K39/275—Poxviridae, e.g. avipoxvirus
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/04—Drugs for skeletal disorders for non-specific disorders of the connective tissue
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A61P25/32—Alcohol-abuse
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/20—Antivirals for DNA viruses
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/525—Virus
- A61K2039/5252—Virus inactivated (killed)
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
- C12N2710/00011—Details
- C12N2710/24011—Poxviridae
- C12N2710/24211—Parapoxvirus, e.g. Orf virus
- C12N2710/24232—Use of virus as therapeutic agent, other than vaccine, e.g. as cytolytic agent
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
- C12N2710/00011—Details
- C12N2710/24011—Poxviridae
- C12N2710/24211—Parapoxvirus, e.g. Orf virus
- C12N2710/24234—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
- C12N2710/00011—Details
- C12N2710/24011—Poxviridae
- C12N2710/24211—Parapoxvirus, e.g. Orf virus
- C12N2710/24261—Methods of inactivation or attenuation
- C12N2710/24264—Methods of inactivation or attenuation by serial passage

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Chemical & Material Sciences (AREA)
General Health & Medical Sciences (AREA)
Medicinal Chemistry (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
Pharmacology & Pharmacy (AREA)
Animal Behavior & Ethology (AREA)
Virology (AREA)
Engineering & Computer Science (AREA)
Organic Chemistry (AREA)
General Chemical & Material Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Chemical Kinetics & Catalysis (AREA)
Bioinformatics & Cheminformatics (AREA)
Immunology (AREA)
Microbiology (AREA)
Epidemiology (AREA)
Mycology (AREA)
Biomedical Technology (AREA)
Zoology (AREA)
Addiction (AREA)
Biotechnology (AREA)
Oncology (AREA)
Genetics & Genomics (AREA)
Communicable Diseases (AREA)
Wood Science & Technology (AREA)
Molecular Biology (AREA)
Neurology (AREA)
General Engineering & Computer Science (AREA)
Physical Education & Sports Medicine (AREA)
Gastroenterology & Hepatology (AREA)
Dermatology (AREA)
Psychiatry (AREA)
Biochemistry (AREA)
Neurosurgery (AREA)
Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Micro-Organisms Or Cultivation Processes Thereof (AREA)

PT01965110T 2000-07-11 2001-07-11 Utilização de estirpes de parapoxvirus ovis contra fibroses de órgãos PT1303302E (pt)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
DE10033581		2000-07-11
DE10122233A DE10122233A1 (de)	2000-07-11	2001-05-08	Verwendung von Stämmen des Parapoxvirus ovis gegen Organfibrosen

Publications (1)

Publication Number	Publication Date
PT1303302E true PT1303302E (pt)	2009-11-11

Family

ID=7648485

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
PT01965110T PT1303302E (pt)	2000-07-11	2001-07-11	Utilização de estirpes de parapoxvirus ovis contra fibroses de órgãos

Country Status (14)

Country	Link
JP (2)	JP5587950B2 (de)
KR (1)	KR100845643B1 (de)
CN (1)	CN101444539B (de)
AT (1)	ATE445413T1 (de)
BR (1)	BRPI0112411B8 (de)
DE (2)	DE10122233A1 (de)
DK (1)	DK1303302T3 (de)
DO (1)	DOP2001000210A (de)
EC (1)	ECSP034420A (de)
ES (1)	ES2332355T3 (de)
PE (1)	PE20020218A1 (de)
PT (1)	PT1303302E (de)
SV (1)	SV2002000527A (de)
ZA (1)	ZA200300276B (de)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
DE102015111756A1 (de) *	2015-07-20	2017-01-26	Eberhard Karls Universität Tübingen Medizinische Fakultät	Rekombinanter Orf-Virus-Vektor
JP6875745B2 (ja) *	2016-02-16	2021-05-26	国立大学法人大阪大学	線維化を治療するための医薬組成物

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
DE4405841C1 (de) *	1994-02-23	1995-01-05	Mayr Anton Prof Dr Med Vet Dr	Multipotente Paramunitätsinducer auf der Basis von Kombinationen von Pockenviruskomponenten, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel
DK0885013T3 (da) *	1996-04-15	2001-11-05	Anton Prof Dr Med Vet Dr Mayr	Anvendelse af multipotente paramunitetsinducere fra svækkede, ikke-immunogene poxvirus eller parapoxvirus til fremstilling af lægemidler

2001
- 2001-05-08 DE DE10122233A patent/DE10122233A1/de not_active Withdrawn
- 2001-07-10 PE PE2001000681A patent/PE20020218A1/es not_active Application Discontinuation
- 2001-07-11 KR KR1020037000310A patent/KR100845643B1/ko not_active Expired - Fee Related
- 2001-07-11 PT PT01965110T patent/PT1303302E/pt unknown
- 2001-07-11 DK DK01965110.8T patent/DK1303302T3/da active
- 2001-07-11 DO DO2001000210A patent/DOP2001000210A/es unknown
- 2001-07-11 CN CN200810149856.XA patent/CN101444539B/zh not_active Expired - Lifetime
- 2001-07-11 AT AT01965110T patent/ATE445413T1/de active
- 2001-07-11 SV SV2001000527A patent/SV2002000527A/es not_active Application Discontinuation
- 2001-07-11 DE DE50115181T patent/DE50115181D1/de not_active Expired - Lifetime
- 2001-07-11 BR BRPI0112411-0 patent/BRPI0112411B8/pt not_active IP Right Cessation
- 2001-07-11 ES ES01965110T patent/ES2332355T3/es not_active Expired - Lifetime
2003
- 2003-01-10 EC EC2003004420A patent/ECSP034420A/es unknown
- 2003-01-10 ZA ZA200300276A patent/ZA200300276B/en unknown
2012
- 2012-06-28 JP JP2012145847A patent/JP5587950B2/ja not_active Expired - Lifetime
2014
- 2014-06-17 JP JP2014124405A patent/JP5950964B2/ja not_active Expired - Lifetime

Also Published As

Publication number	Publication date
ES2332355T3 (es)	2010-02-03
BR0112411A (pt)	2003-05-27
JP2014196329A (ja)	2014-10-16
JP5950964B2 (ja)	2016-07-13
BRPI0112411B8 (pt)	2021-05-25
KR100845643B1 (ko)	2008-07-10
KR20030019562A (ko)	2003-03-06
DE50115181D1 (de)	2009-11-26
DOP2001000210A (es)	2002-12-15
DE10122233A1 (de)	2002-01-24
ZA200300276B (en)	2004-04-13
JP2012214492A (ja)	2012-11-08
CN101444539B (zh)	2016-07-06
ECSP034420A (es)	2003-03-10
SV2002000527A (es)	2002-10-24
DK1303302T3 (da)	2010-02-08
BRPI0112411B1 (pt)	2018-02-27
CN101444539A (zh)	2009-06-03
ATE445413T1 (de)	2009-10-15
PE20020218A1 (es)	2002-05-19
JP5587950B2 (ja)	2014-09-10

Publication	Publication Date	Title
Janbaz et al.	2002	Protective effect of rutin on paracetamol-and CCl4-induced hepatotoxicity in rodents
CY2241B1 (en)	2003-07-04	Fluoxetine pharmaceutical formulations
AR024579A1 (es)	2002-10-16	Combinacion de bacterias de acido lactico y su uso para la prevencion y/o tratamiento de infecciones y condiciones inflamatorias.
MY144292A (en)	2011-08-29	Method of reducing oral tissue inflammation using magnolia extract
CA2504872A1 (en)	2004-05-21	Use of resveratrol for the preparation of a medicament useful for the treatment of influenza virus infections
PT1303302E (pt)	2009-11-11	Utilização de estirpes de parapoxvirus ovis contra fibroses de órgãos
WO2001057072A3 (en)	2002-10-31	Pharmacologically active antiviral peptides and methods of their use
MXPA05005911A (es)	2005-08-29	Utilizacion del acido docosahexaenoico como sustancia activa para el tratamiento de la lipodistrofia.
HU227668B1 (en)	2011-11-28	Use of strains of the parapox ovis virus against organ fibrosis
EP1038529A3 (de)	2002-05-02	Wirkstoff zur Erhöhung der Chemokinproduktion
Vazquez	1996	How low can you go
Septiana et al.	2021	The role of Wanagama as a healing forest during the pandemic covid 19
CN1126565C (zh)	2003-11-05	一种治疗病毒性耳聋的中药外用制剂
Baishya	1996	Topical ketoconazole therapy in a recalcitrant case of seborrhoeic dermatitis
Mishriki	1997	The case of the creeping papules
Nakashima et al.	2004	Mothproofing efficacy of wool-yarn treated with several kinds of medical herb against to cloth moth, Tinea Pellionella (L.)
Shigematsu et al.	2000	Average life span of a Japanese tooth
Fox	2001	Stop Trying Too Hard to Kill Bacteria
Ishak et al.	2000	A13 Oral infection of Aedes aegypti and Aedes albopictus with Dengue-1 viruses: Susceptibility comparison and molecular analysis
Nagatsuka et al.	2004	Effect of Ingredients and Heating Conditions in" Nikogori" on the Incidence of Active Oxygen
鄭介原 et al.	2002	Multiple Cystic Ameloblastoma: A Case Report
ES2130069B1 (es)	2000-03-01	Preparacion farmaceutica con liberacion retardada del producto activo.
Knill	2000	OSHA Backpedals on Standard.
AP2001002323A0 (en)	2001-12-31	The use of aqueous herbal preparation, pmz10, as an alternative remedy in the treatment of HIV/AIDS.
ES2103691A1 (es)	1997-09-16	Uso del extracto de euphorbia characias para la fabricacion de un medicamento util para la prevencion y tratamiento de papilomas, verrugas y micosis en humanos y animales.